(26) In a follow-up study, Werkman et al
The study found that in a pool of 16,827 patients, nonarteritic anterior ischemic optic Neuropathy (NAION) increased more than four times for people taking semaglutide compared to those who took another drug
GLP-1 Medications Interviewer: So I guess that leads me to the big question I think on everybody's minds right now is GLP-1s, right
She has to prepare a separate dinner for her son who dislikes her now-bland recipes: "Sometimes it's like 'Gosh, I really want this.'" New tastes can crop up, too
Less commonly reported adverse reactions (less than 1% or less than twice rate of placebo) included increased heart rate, headache, abdominal pain upper, dyspnea, rash, insomnia, irritability, feeling jittery and anxiety